CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +12,037 | 33,516 | ||
| 2022-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,539 | $25.01 | $89K | 29,977 |
| 2022-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −12,037 | 36,114 | ||
| 2022-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,969 | 28,079 | ||
| 2022-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,041 | $25.01 | $51K | 26,038 |
| 2022-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,969 | 20,908 | ||
| 2022-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,543 | 234,768 | ||
| 2022-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,462 | $25.01 | $62K | 232,306 |
| 2022-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,543 | 16,632 | ||
| 2022-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +9,503 | 90,709 | ||
| 2022-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −2,794 | $25.01 | $70K | 87,915 |
| 2022-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −9,503 | 28,511 | ||
| 2022-02-22 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise | +7,286 | 99,909 | ||
| 2022-02-22 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,143 | $25.01 | $54K | 97,766 |
| 2022-02-22 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,286 | 21,858 | ||
| 2022-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +6,969 | 61,955 | ||
| 2022-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −2,049 | $25.01 | $51K | 59,906 |
| 2022-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −6,969 | 20,908 | ||
| 2022-02-21 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +6,875 | 23,501 | ||
| 2022-02-21 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −2,022 | $25.08 | $51K | 21,479 |
Page 53 of 60 · 1,194 trades